In Association With Cytiva

Accelerating Biopharmaceutical Innovation

Partner Content

The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know

In the genomic medicine toolbox, oligonucleotide therapeutics offer highly specific and effective treatments for both rare diseases and more common conditions. Katarina Stenklo, Global FlexFactory™ Product Manager at Cytiva, and Carina Andersson, Senior Global Product Manager in Genomic Medicine at Cytiva, discuss the oligonucleotide therapeutic market and solutions to help overcome challenges when scaling up.

Partner Content

The state of the diagnostic industry: cautious optimism for the coming years

Partner Content

Translational research: Out of the lab, into the clinic

Partner Content

Sustainability in biopharma: The challenges of ESG 2.0

Partner Content

The transformative impact of digitalization in biopharma

Partner Content

Modernizing cell culture processes for the next wave of genomic medicine

Partner Content

How competitors are collaborating to shape biopharma best practices and regulations of the future

Partner Content

Lab to jab in 100 days: manufacturing flexibility for future rapid responses

Partner Content

How resilient is the global biopharma industry?

Partner Content

Rethinking SUT’s environmental impact: Can single-use technology be sustainable?

Miranda McLaren

Partner Content

Building capacity for new modalities: Inside Cytiva’s first end-to-end cGMP facility for mRNA manufacturing

Partner Content

Biopharma revolutionaries lead the way as the pharmaceutical sector edges towards Industry 4.0

Partner Content

Buy or build: Strategies to meet demand for vaccine and viral vector production

Partner Content

Biopharma 4.0: The real-world benefits of modern manufacturing

Partner Content

Trends in biopharma: the future of manufacturing

Partner Content

Is your single-use facility designed with the end in mind?

Partner Content

Strategies to address the viral vector manufacturing shortage

Partner Content

Viral vector manufacturing: design considerations to improve commercial success

Partner Content

A standard approach to drug development for accessing the globe

Partner Content

Developing a new biologic drug: regulatory challenges and considerations

Partner Content

Implementing the ballroom concept for biomanufacturing: Lessons, reflections and considerations from experience

Most Popular

Partner Content

The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know

Partner Content

The state of the diagnostic industry: cautious optimism for the coming years

Partner Content

Translational research: Out of the lab, into the clinic

Partner Content

Sustainability in biopharma: The challenges of ESG 2.0

White Papers

Cytiva

Environmental monitoring for closed robotic workcells used in aseptic processing

Sign up to the newsletter: In Brief

Your corporate email address *

First name *

Last name *

Company name *

Job title *

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close